INIS
thrombin
100%
estrogens
68%
proteins
52%
comparative evaluations
43%
women
41%
concentration
38%
performance
36%
sensitivity
36%
interlaboratory comparisons
34%
heparin
34%
data
30%
values
30%
plasma
28%
receptors
25%
risks
24%
reagents
24%
range
23%
evaluation
23%
patients
21%
standardization
19%
in vitro
19%
peaks
19%
volume
17%
cancer
17%
healing
17%
hemostatics
17%
antigens
17%
breasts
17%
hematology
17%
ruptures
17%
tamoxifen
17%
tendons
17%
failures
17%
reviews
17%
pregnancy
17%
antibodies
17%
tissues
14%
strains
14%
detection
14%
phospholipids
12%
immunity
12%
capacity
12%
blood cells
11%
laboratories
10%
blood
10%
anticoagulants
9%
inhibition
9%
doses
9%
steroids
9%
fetuses
8%
Pharmacology, Toxicology and Pharmaceutical Science
Thrombin
83%
Activated Protein C Resistance
56%
Oral Contraceptive Agent
45%
Venous Thromboembolism
36%
Activated Protein C
30%
Hexadimethrine Bromide
26%
Ethinylestradiol
23%
Estetrol
19%
Thromboplastin
18%
Heparin
17%
Estrogen Receptor Positive Breast Cancer
17%
Hemostatic Agent
17%
Observational Study
17%
Tamoxifen
17%
Atrial Fibrillation
17%
Pharmacodynamics
17%
Phospholipid
17%
Disproportionality Analysis
17%
Infection
17%
SARS Coronavirus
17%
Neutralizing Antibody
17%
Estrogen Receptor
16%
Estrogen Derivative
10%
Progestin
8%
Diethylstilbestrol
8%
Placebo
8%
Blood Stasis
8%
Heparin Lyase
7%
Breast Cancer
7%
Epileptic Absence
7%
APC
6%
Contraceptive Agent
5%
Calcium Ion
5%
Keyphrases
Polybrene
17%
Volume Standards
17%
Analytical Sensitivity
17%
SARS-CoV-2 Antigen
17%
Delta Variant
17%
Mean Platelet Volume
17%
Achilles Tendon Healing
17%
Leukocyte-rich PRP
17%
Achilles Tendon Rupture
17%
Estrogen Receptor-positive Breast Cancer
17%
Breast Cancer
17%
Breast Cancer Patients
17%
Activated Protein C
17%
Asundexian
17%
Literature Review Analysis
17%
Venous Thromboembolic Events
17%
EudraVigilance Database
17%
Combined Oral Contraceptives
17%
Natural Estrogens
17%
Disproportionality Analysis
17%
Ethinylestradiol
17%
Omicron Sub-lineages
17%
Estrogen Receptor
13%
Reporting Rate
10%
Low Viral Load
10%
Poor Performance
10%
Activated Protein C Resistance
10%
Endogenous Thrombin Potential
10%
Thrombin Generation Assay
10%
Delta Strain
6%
Omicron Strain
6%
C Concentration
6%
Sensitivity Ratio
6%
Adjuvant Therapy
6%
Remission
6%
Synthetic Estrogen
6%
Vasomotor Symptoms
5%
Membrane-initiated Steroid Signaling
5%
Neutralizing Capacity
5%